Faites connaître ce site 
 Et retrouvez nous sur : 
(Bienvenue (username). (Déconnecter) / Déconnecté - connexion)
Ctrl F5 pour raffraichir la page
 ASSOCIATION REVAV 
ACCIDENTS DES VACCINS CONTRE L’HÉPATITE B DANS LA LITTERATURE MEDICALE
ACCIDENTS LOCAUX (AU POINT D’INJECTION)
Granulome par sensibilisation à l’aluminium
Mastocytose
POULTON JK. Solitary mastocytoma arising at a hepatitis B vaccination site. Cutis. 1999; 63(1):37-40
COSNES A, FLECHET ML, REVUZ. Inflammatory nodular reaction after hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis 1990; 23 :65-67

HUTTEROTH TH, QUAST U. Aluminiumhydroxid-granulome nach hepatitis-B impfung. Deutsch Med Wochensch. 1990; 115(12):476

SKOWRON F, GREZARD P, BERARD F, BALME B, PERROT H. Persistent nodules at sites of hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis. 1998; 39(3):135-136

AJITHKUMAR K, ANAND U, PULIMOOD S, CHANDI SM, GEORGE S, JACOB CK, THOMAS PP. Vaccine-induced necrobiotic granuloma. Clin Exp Dermatol. 1998; 23(5):222-224
Nodules inflammatoires par sensibilisation au Thiomersal
NOEL I, GALLOWAY A, IVE FA. Hypersensitivity to thiomersal in hepatitis B vaccine. Lancet 1991; 338:705

RIETSCHEL RL, ADAMS RM. Reactions to thimerosal in hepatitis B vaccine. Dermatol. Chrs. 1990; 8:161-164
Zona en regard du point d’injection
NUTINI MT. Pharmacovigilance Hevac B Pasteur J.Am.Med.Assoc. (suppl. hors série) 1987 :5-7
AFFECTIONS ALLERGIQUES
Urticaires et rashs éruptifs
Oedème de Quincke et choc anaphylactique
GOLDWATER PN. Hypersensitivity to intradermal hepatitis B vaccine. Lancet 1984; 17:1156 

DE SILVA L, ROGERS M. Hepatitis B vaccine: urticarial reaction. Med.J.Austr. 1985; 143:323-324

TOSTI A, MELION M, BARDAZZI F. systemic reactions due to thimerosal. Contact Dermatitis. 1986; 15:187-188

PIERCHALLA P, PETRI H, RUPING K. Urticaria after HB-Vax injection due to hypersensitivity to thiomersal (merthiolate). Allergologie 1987; 10:97-99

LOHIYA G. Asthma and urticaria after hepatitis B vaccination. The Western J. Med. 1987; 147:341

NUTINI MT. Pharmacovigilance Hévac B Pasteur J.Am.Med.Assoc. (suppl. hors série) 1987 :5-7

BRIGHTMAN CAJ, SCADDING GK, DUMBRECK IA, ATCHMAN Y, BROSTOFF J. Yeast-derived hepatitis B vaccine and yeast sensitivity. Lancet 1989; 333:903

ANDRÉ FE. Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine 1990; 8:74-78

Mc MAHON BJ, HELMINIAK C, WAINWRIGHT RB, BULKOW L, TRIMBLE BA, WAINWRIGHT K. Frequency of adverse reactions to hepatitis B vaccine in 43618 persons. Am.J.Med. 1992; 92:254-256

HUDSON TJ, NEWKIRK M, GERVAIS F, SHUSTER J. Adverse reaction to the recombinant hepatitis B vaccine. J.Allergy Clin. Immunol.1991;88:821-822 (avec erratum dans J.Allergy Clin. Immunol. 1993; 92 :498)

NAGAFUCHI S, TOKIYAMA K, KASHIWAGI S, YAYASHI S, IMAYAMA S, NIHO Y. Eosinophilia after intradermal hepatitis B vaccination. Lancet 1993; 342: 995

FROEHLICH H, VERMA R. Arthus reaction to recombinant hepatitis B virus vaccine. Clin Infect Dis. 2001 Sep 15; 33(6):906-8

BECKER BA. A severe allergic reaction presenting as an asthma exacerbation with respiratory failure following Hepatitis B vaccination. Journal of Allergy and Clinical Immunology. 2002 Jan; 109(1) Part Two
NUTINI MT. Pharmacovigilance Hévac B Pasteur. J.Am. Med. Assoc. (supplément hors série) 1987: 5-7

LEAR JT, ENGLISH JSC. Anaphylaxis after hepatitis B vaccination. Lancet 1993; 345: 1249

BARBAUD A, TRECHOT P, REICHERT-PENETRAT S, WEBER M, SCHMUTZ JL Allergic mechanisms and urticaria/angioedema after hepatitis B immunization. Br J Dermatol. 1998 Nov; 139(5):925-6

ARKACCHAISRI T. Serum sickness and hepatitis B vaccine including review of the literature. J Med Assoc Thai. 2002 Aug;85 Suppl 2:S607-12

SAVI E, MAFFINI I, BURASTERO SE. A latex-containing hepatitis-B vaccine administered in a severely latex allergic paediatric patient after specific sublingual immunotherapy: a case report. Allergy. 2004 Sep; 59(9):1014-5
AFFECTIONS DERMATOLOGIQUES
Alopécie
NOBLES JP, DE GENNES C, BOUSQUET O. Skin diseases related to hepatitis B vaccine. Gastroenterol.Clin.biol 1997; 21(1) :87
WISE RP, KIMINYO KP, SALIVE ME. Hair loss after routine immunizations. JAMA. 1997; 278(14):1176-8

SEPKOWITZ S. Hair loss after immunization. JAMA. 1998; 279(2):117-8

SUNBERG JP, SILVA KA, ZHANG W, SUNBERG BA, EDWARDS K, KING LE, DAVIS RL, BLACK S. Recombinant human hepatitis B vaccine initiating alopecia areata: testing the hypothesis using the C3H/HeJ mouse model. Vet Dermatol. 2009 Jan 17
Anétodermie
DAOUD MS, DICKEN CH. Anetoderma after hepatitis B immunization in two siblings. J.Am.Acad.Dermatol. 1997;36(5 Pt 1):779-780
Eczéma par sensibilisation au formaldéhyde
Erythème noueux
RING J. Exacerbation of eczema by formalin-containing hepatitis B vaccine in formaldehyde-allergic patients. Lancet 1986; 522-523

Mc KENNA KE. Eczematous reaction to hepatitis B vaccine. Contact Dermatitis. 1999; 40(3):158-9
MAGGIORE G, GRIFEO S, MANZNI MD. Erythema nodosum and hepatitis B virus infection. J.Am.Acad.Dermatol. 1983; 9:602-603

DI GIUSTO CA, BERNHARD JD. Erythema nodosum provoked by hepatitis B vaccine. Lancet 1986; ii:1042

GOOLSBY PL. Erythema nodosum after recombinant hepatitis B vaccine. N.Engl.J.Med. 1989; 21:1198-119

ROGERSON ST , NYE FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. Br. Med. J. 1990; 301:345

CASTRESANA-ISLA CJ, HERRERA-MARTINEZ G,VEGA-MOLINA J. Erythema nodosum and Takayasu’s arteritis after immunization with plasma derived hepatitis B vaccine. J. rhumatol.1999; 20:1417-1418
Erythermalgie
RABAUD C. First case of erythermalgia related to hepatitis B vaccination. J.Rheumatol.1999; 26(1):233-234
Erythème polymorphe
FELDSHON SD, SAMPLINER RE. Reaction to hepatitis B virus vaccine. Ann. Inter. Med. 1984; 100(1):156-157

WAKEEL RA, WHITE MI. Erythema multiforme associated with hepatitis B vaccine. Br. J. Dermatol. 1992; 126:94-95

MILSTIEN JB, KURITSKY JN. Erythema multiforme and hepatitis B immunization. Arch. Dermatol. 1986; 122:511-512

DI LERNIA V, LO SOCCO G, BISIGHINI G. Erythema multiforme following hepatitis B vaccine. Pediatric Dermatol. 1994; 4:363-364

LOCHE F, SCHWARZE HP, THEDENAT B, CARRIERE M, BAZEX J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol. 2000; 25(2):167-168 
Granulome annulaire
GREZARD P. Accidents de la vaccination contre l’hépatite B : à propos de 9 cas observés de début 1994 à fin 1995. Thèse LYON I. 1996: 79-83

WOLF F, GREZARD P , BERARD F , CLAVEL G , PERROT H. Generalized granuloma annulare and hepatitis B vaccination. Eur J Dermatol. 1998; 8(6):435-436

CRIADO PR, DE OLIVEIRA RAMOS R, VASCONCELLOS C, JARDIM CRIADO RF, VALENTE NY. Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare. J Eur Acad Dermatol Venereol. 2004; 18(5):603-6
Lichen plan
CIACCO M, REBORA A. Lichen planus following HB vaccination: a coincidence? Br. J. Dermatol. 1990; 122(3):424

TREVISAN G, STINCO G. Lichen rubber planus following HB vaccination. Acta Dermatol. Venereol. 1993; 73:73

PUSEL B, WILL F, GROSSHANS E. Lichen plan et vaccination contre l’hépatite B. Nouv. Dermatol.1994; 130:1329-1330

AUBIN F, ANGONIN R, HUMBERT P, AGACHE P. Lichen planus following hepatitis B vaccination. Arch. Dermatol. 1994; 130:1329-1330

LEPORT Y. Lichen plan et vaccination contre l’hépatite B. Nouv. Dermatol. 1995; 14:594

GREZARD P, PHILIPPOT V, PERROT H. Lichen plan et vaccination contre l’hépatite B. Nouv. Dermatol. 1995; 14:444-445

LEFORT A, DACHARY D, VERGIER B, BOIRON G. Lichen plan et vaccination anti-hépatite B. Ann. Dermatol. Venereol. 1995; 122:701-703

SAYWELL CA, WITTAL RA, KOSSARD S. Lichenoid reaction to hepatitis B vaccination. AUSTRALAS J Dermatol. 1997; 38(3):152-4

GISSEROT O, CARSUZAA F, MARLIER S, MORAND JJ, MARROT E. Lichen planus after hepatitis B vaccination. 3 new cases. Presse Med. 1997; 26(16):760

FERRANDO MF, DOUTRE MS, BEYLOT-BARRY M, DURAND I, BEYLOT C. Lichen planus following hepatitis B vaccination. Br J Dermatol. 1998; 139(2):350

LACOUR JP. Hepatitis, the vaccine, multiple sclerosis and lichen: the story and its morale. Ann Dermatol Venereol. 1998; 125(6-7):395-7

REBORA A. Lichen planus as a side effect of HBV vaccination. Dermatology 1999; 198(1):1-2

BARDAZZI F, LANDI C, ORLANDI C, NERI I, VAROTTI C. Graham Little-Piccardi-Lasseur syndrome following HBV vaccination. Acta derm Venereol. 1999;79(1):93 SCHUPP P, VENTE C. Lichen planus following hepatitis B vaccination. Int J Dermatol. 1999; 38(10):799-800

AL-KHEINAIZAN S. Lichen planus occurring after hepatitis B vaccination : a new case. J Am Acad Dermatol. 2001; 45(4):614-5

USMAN A, KIMYAI-ASADI A, STILLER MJ, ALAM M. Lichenoid eruption following hepatitis B vaccination: first North American case report. Pediatr Dermatol. 2001; 18(2):123-6

DRAGO F, REBORA A. Cutaneous immunologic reactions to hepatitis B virus vaccine. Ann Internal Med. 2002; 136(10):780

DARAMOLA OO, OGINBIYI AO, GEORGE AO. Lichen planus following hepatitis B vaccination in an African girl. Trop Doct. 2002; 32(2):117-118

STAVRIANEAS NG, KATOULIS AC, KANELLEAS A, HATZIOLOU E, GEORGAL S. Papulonodular lichenoid and pseudolymphomatous reaction at the injection site of hepatitis B virus vaccination. Dermatology 2002; 205(2):166-8
Lupus érythémateux cutané
GREZARD P. Accidents de la vaccination contre l’hépatite B : à propos de 9 cas observés de début 1994 à fin 1995. Thèse LYON I. 1996; 106-109

CHOFFRAY A, PINQUIER L, BACHELEZ H. Exacerbation of lupus panniculitis following anti-hepatitis-B vaccination. Dermatology 2007; 215(2):152-4
Pemphigoide bulleuse
ERBAGCI Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol. 2002 Dec; 29(12):781-5
Psoriasis
MORRIS CA, OLIVIER PR, REYNOLDS F, SELKON JB. Intradermal hepatitis B immunization with yeast-derived vaccine : serological response by sex and age. Epidemiol. Infect. 1989; 103 :387-394

Morbidity and mortality weekly report. Safety of hepatitis B vaccine. J.Am.Med. Assoc. 1983; 249:1812

AHERNE P, COLLINS M. Psoriatic arthropathy. Irish Med J. 1995; 88:72
Sclérodermie en plaques
GREZARD P. Accidents de la vaccination contre l’hépatite B : à propos de 9 cas observés de début 1994 à fin 1995. Thèse LYON I. 22 avril 1996; 84-87

SCHMUTZ JL, POSTH M, GRANEL F, TRECHOT P, BARBAUD A. Localized scleroderma after hepatitis B vaccination. Presse Med. 2000; 29(19):1046

TORRELO A, SUAREZ J, COLMENERO I, AZORIN D, PERERA A, ZAMBRANO A. Deep morphea after vaccination in two young children. Pediatr Dermatol. 2006; 23(5):484-7
Syndrome de Gianotti-Crosti
GIAM YC, TAY YK. Gianotti-Crosti syndrome: a review of 22 cases. J.Singapore Paediatr.Soc. 1993; 35:139-146

TAY YK. Gianotti-Crosti syndrome following immunization. Pediatr Dermatol . 2001 May-Jun; 18(3):262

ANDIRAN N, SENTURK GB, BUKULMEZ G. Combined vaccination by measles and hepatitis B vaccines: a new cause of Gianotti-Crosti syndrome. Dermatology. 2002; 204(1):75-6

HAUG S, SCHNOPP C, RING J, FOLSTER-HOLST R, ABECK D. Gianotti-Crosti syndrome following immunization. Hautarzt. 2002; 53(10):683-5

KARAKAS M, DURDU M, TUNCER I, CEVLIK F. Gianotti-Crosti syndrome in a child following hepatitis B virus vaccination. J Dermatol. 2007;34(2):117-20
AFFECTIONS AUTO-IMMUNES ET CONNECTIVITES
Cryoglobulinémie
Lupus erythémateux disséminé (LED)
MATHIEU E, FAIN O, KRIVITZKY A. Cryoglobulinemia after hepatitis B vaccination. N Engl J Med. 1996; 335(5):355

KRIVITZKY A, GAUDOUEN Y, BENTATA M. OLSCHWANG M. Cryoglobulinémie après vaccination contre l'hépatite B. Communication au congrès de la société nationale française de médecine interne. Reims ; 8-10-1994
T UDELA P, M ARTI S, BONAL J. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron. 1992; 62(2):236

MAMOUX V, DUMONT C. Lupus érythémateux disséminé et vaccination contre l’hépatite B. Arch. Pédiatr. 1994; 1 :306-310

NUTINI MT. Pharmacovigilance Hévac B Pasteur. J. Am Med Assoc. (supplément hors série) 1987; 5-7

GUISERIX J. Systemic lupus erythematosus following hepatitis B vaccine. Nephron. 1996; 74(2):441

DELBREL X, FACH J, NEAU D, LAMARQUE P, LONGY-BOURSIER M, LE BRAS M Poussée lupique après vaccination contre l’hépatite B : un nouveau cas. Rev Méd. Interne 1997; 18 (suppl 2) poster 27:160s

FINIELZ P, LAM-KAM-SANG LF, GUISERIX J. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrol Dial Transplant. 1998; 13(9):2420-1

BATTAFARANO DF and al. Antigen-specific antibody responses in lupus patients following immunization. Arthritis Rheum. 1998; 41(10):1828-34

SENECAL JL, BERTRAND C, COUTLEE F. Severe exacerbation of systemic lupus erythematosus after hepatitis B vaccination and importance of pneumococcal vaccination in patients with autosplenectomy: comment on the article by Battafarano et al. Arthritis Rheum. 1999; 42(6):1307-8

HANSLIK T, VAILLANT JN, AUDRAIN L, JUBAULT V, PRINSEAU J, BAGLIN A, FLAHAUT A. Systemic lupus erythematosus and risk of hepatitis B vaccination: from level of evidence to prescription . Rev Med Interne. 2000; 21(9):785-90

SHAPIRO E, KOPICKY J. Comment on the article "can immunization precipitate connective tissue disease? Report of 5 cases of systemic lupus erythematosus and review of the literature". Semin. Arthritis Rheum. 2000; 30(3):215-6

FINESCHI S. Can recombinant anti-hepatitis B vaccine be a cause of systemic lupus erythematosus? Lupus. 2001; 10(11):830

POIRRIEZ J. A preliminary experiment of absorption of antinuclear antibodies by the hepatitis B vaccine components, in a case of neurolupus. Vaccine 2004, 22: 3166-3168

MARTINUC POROBNIC J, AVCIN T, BOZIC B, KUHAR M, CUCNICS, ZUPANCIC M, PROSENC K, KVEDER T, ROZMAN B. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol. 2005; 142(2): 377-80  
 
SANTORO D, STELLA M, MONTALTO G, CASTELLINO S. Lupus nephritis after hepatitis B vaccination: an uncommon complication. Clin Nephrol. 2007 Jan; 67(1):61-63

KURUMA KA, BORBA EF, LOPES MH, DE CARVALHO JF, BONFA E. Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus. Lupus. 2007; 16(5):350-4
Dermatomyosite et polymyosite
FERNANDEZ-FUNEZ A, POLO-ROMERO FJ. Juvenile dermatomyositis concomitant with hepatitis B vaccination. Med Clin (Barc). 1998; 111(17):675

RAMIREZ-RIVERA J, VEGA-CRUZ AM, JAUME-ANSELMI F. Polymyositis: rare complication of hepatitis B vaccination. An unusual cause of toxic shock syndrome. Bol Asoc Med P R. 2003 Nov-Dec; 95(6):13-6

ALTMAN A, SZYPER-KRAVITZ M, SHOENFELD Y. HBV vaccine and dermatomyositis: is there an association ? Rheumatol Int. 2008 Apr; 28(6):609-12
Diabète insulino-dépendant
CLASSEN JB. Childhood immunisation and diabetes mellitus. N Z Med J. 1996; 109(1022):195

CLASSEN JB. The diabetes epidemic and the hepatitis B vaccines. N Z Med J. 1996; 109(1030):366

PETOUSIS-HARRIS H, TURNER N. Hepatitis B vaccination and diabetes. N Z Med J. 1999; 112(1093):303-304

GRAVES PM, BARRIGA KJ, NORRIS JM, HOFFMAN MR, YU L, EISENBARTH GS, REWERS M. Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care. 1999; 22(10):1694-1697

THIVOLET C, VIALETTES B, BOITARD C, BRINGER J. Absence of evidence of a possible connection vaccination for hepatitis B and the development of diabetes type 1. Report of a group of ALFEDIAM experts. Diabetes Metab. 1999; 25(5):441-445
Myasthénie
BIRON P, MONTPETIT P, INFANTE-RIVARD C, LERY L, Myasthenia gravis after general anaesthesia and hepatitis B vaccine. Arch.Intern. med.1988; 148:2685

DOMINGO V, AUTHIER FJ, BACHOUD-LEVI AC,, GHERARDI RK,DEGOS JD. Should hepatitis B vaccine be contra-indicated in myasthenia gravis? Autoimmunity. 1999; 29(2)139-140

LOUZIR B, OTHMANI S, BATTIKH R, BEN ABDELHAFIDH N, TAALOUCHE L, BAHRI M. Myasthenia after hepatitis B vaccination. Therapie 2003; 58(4):378-379
Périartérite noueuse (PAN)
CUPPS TR, GOLDSMITH PK, VOLKMAN DJ, GERIN JL, PURCELL RH, FAUCI AS. Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. Cell Immunol. 1984; 86(1):145-54

LE GOFF P, FAUQUERT P,YOUINOU P, HOANG S. Périartérite noueuse après vaccination contre l’hépatite B. Press. Med. 1988; 17:1763

Mc MAHON BJ, HEYWARD WL, TEMPLIN DW, CLEMENT D, LANIER AP. Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology. 1989 Jan; 9(1):97-101

GATEL A, CACOUB P,SBAI A,MAISONNOBE T, LUNEL F,ELIASZEWICZ D,PIETTE JC, GODEAU P. Périartérite noueuse systémique après vaccination contre l’hépatite B. Rev. Méd. Interne 1996; 17(suppl.3) poster 119:467s

KERLEAU JM, LEVESQUE H, LAIR G, LECOMTE F, CARRARA O, COURTOIS H. Is hepatitis B vaccination a new cause of necrotizing vasculitis ? Rev Med Interne. 1997; 18(6):491-2

DE KEYSER F, NAEYAERT JM, HINDRYCKX P, ELEWAUT D, VERPLANCKE P, PEENE I, PRAET M, VEYS E. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clin Exp Rheumatol. 2000 Jan-Feb; 18(1):81-5

SAADOUN D, CACOUB P, MAHOUX D, SBAI A, PIETTE JC. Postvaccine vasculitis: a report of three cases Rev Med Interne. 2001 Feb; 22(2):172-6

BOURGEAIS AM, DORE MX, CROUE A, LECLECH C, VERRET JL. Cutaneous polyarteritis nodosa following hepatitis B vaccination. Ann Dermatol Venereol. 2003 Feb; 130(2 Pt 1):205-7
Vascularites
COCKWELL P, ALLEN MB, PAGE RL. Vasculitis related to hepatitis B vaccine. Br. Med. J. 1990; 301:1281

CARMELI Y, OREN R. Hepatitis B vaccine side-effect. Lancet 1993; 341: 250-251

ALLEN MB, COCKWELL P, PAGE RL. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax 1993;48:580-581

CASTRESANA-ISLA CJ, HERRERA-MARTINEZ G, VEGA-MOLINA J. Erythema nodosum and Takayasu's arteritis after immunization with plasma derived hepatitis B vaccine. J Rheumatol. 1993; 20(8):1417-8

KRIVITZKY A, GAUDOUEN Y, BENTATA M, OLSCHWANG M. Cryoglobulinémie après vaccination contre l’hépatite B. Communication au congrès de la société nationale française de médecine interne. Reims; 8-10 1994

LE HELLO C, COHEN P, GUIILEVIN L. Vascularite leucocytoclasique après une vaccination contre l’hépatite B. Rev. Med. Inter. 1995; 16:poster 174

GREZARD P. Accidents de la vaccination contre l’hépatite B : à propos de 9 cas observés de début 1994 à fin 1995. Thèse LYON I. 1996:92-99

KERLEAU JM, LEVESQUE H, LAIR G, LECOMTE F, CARRARA O, COURTOIS H. Is hepatitis B vaccination a new cause of necrotizing vasculitis ? Rev Med Interne. 1997; 18(6):491-492

DRUCKER Y, PRAYSON RA, BAGG A, CALABRESE LH. Lymphocytic Vasculitis Presenting as Diffuse Subcutaneous Edema After Hepatitis B Virus Vaccine. J Clin Rheumatol. 1997; 3(3):158-161

VANOLI M, GAMBINI D, SCORZA R. A case of Churg-Strauss vasculitis after hepatitis B vaccination. Ann Rheum Dis. 1998; 57(4):256-7

MASSE I, DESCOFFRES MC. Hypersensitivity vasculitis after hepatitis B vaccination.  Presse Med. 1998; 27(20):965-6

GRASLAND A, LE MAITRE F, POUCHOT J, HAZERA P, BAZIN C, VINCENEUX P. Adult-onset Still's disease after hepatitis A and B vaccination ? Rev Med Interne. 1998; 19(2):134-6

BUI-QUANG D, THOMAS E, RIOLS M, LEVILLAIN P, PICAUD D, SECHET A, BARON M, VEROVE C. Cutaneous vasculitis after hepatitis B vaccination with recombinant vaccine in a renal transplant patient. Presse Med. 1998; 12;27(26):1321-1323

CASTRESANA-ISLA CJ, HERRERA-MARTINEZ G,VEGA-MOLINA J. Erythema nodosum and Takayasu’s arteritis after immunization with plasma derived hepatitis B vaccine. J. rhumatol.1999; 20:1417-1418

LE HELLO C, COHEN P, BOUSSER MG, LETELLIER P, GUILLEVIN L. Suspected hepatitis B vaccination related vasculitis. J Rheumatol. 1999; 26(1):191-4

SAADOUN D, CACOUB P, MAHOUX D, SBAI A, PIETTE JC. Postvaccine vasculitis : a report of three cases Rev Med Interne. 2001; 22(2):172-6

ZAAS A, SCHEEL P, VENBRUX A, HELLMANN DB. Large artery vasculitis following recombinant hepatitis B vaccination : 2 cases. J Rheumatol. 2001; 28(5):1116-20

BERETTA L, CARONNI M, VANOLI M, SCORZA R. Churg-Strauss vasculitis with brain involvement following hepatitis B vaccination. Clin Exp Rheumatol. 2001; 19(6):757

CHAVE T, NEAL C, CAMP R. Henoch-Schönlein purpura following hepatitis B vaccination. J Dermatolog Treat. 2003; 14(3):179-81.

MIRON D, FINK D, HASHKES PJ. Kawasaki disease in an infant following immunisation with hepatitis B vaccine. Clin Rheumatol. 2003; 22(6):461-3
Syndrome de Gougerot-Sjögren
TOUSSIROT E, LOHSE A, WENDLING D, MOUGIN C. Sjögren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum. 2000 Sep; 43(9):2139-40
Syndrome néphrotique
NUTINI MT , MARIE FN, LOUC C, TRON F. Hepatitis B vaccine clinical experience and safety. Lancet 1985; ii :1301

MACARIO F, FREITAS L, CORREIA J, CAMPOS M. Nephrotic syndrome after recombinant hepatitis B vaccine. Clin. Nephrol. 1995; 43:349

OZDEMIR S, BAKKALOGLU A, ORAN O. Nephrotic syndrome associated with recombinant hepatitis B vaccination: a causal relationship or just a mere association ? Nephrol Dial Transplant. 1998 Jul; 13(7):1888-9

ISLEK I, CENGIZ K, CAKIR M, KUCUKODUK S. Nephrotic syndrome following hepatitis B vaccination. Pediatr Nephrol. 2000 Jan; 14(1):89-90
Thyroidites auto-immunes (Thyroïdite de Hashimoto, maladie de Basedow)
TOFT I, LARSEN S, TOFT H. Subacute thyroiditis after hepatitis B vaccination. Endocr. J. 1998 Feb; 45(1):135

YU O, BOHLKE K, HANSON CA, DELANEY K, REES TG, ZAVIKOVSKY A, RAY P, MULLOLY J, BLACK SB, BENSON P, THOMSON WW, DAVIS RL, JACKSON LA. Hepatitis B vaccine and risk of autoimmune thyroid disease : a Vaccine Safety Datalink study. Pharmacoepidemiol Drug Saf. 2007 Jul; 16(7):736-45
AFFECTIONS HEMATOLOGIQUES
Pancytopénie (Anémie, thrombopénie et leucopénie)
Thrombopénie (Baisse des plaquettes)
POULLIN P, GABRIEL B. Thrombocytopenic purpura after recombinant hepatitis B vaccine. Lancet 1994; 344:1293

MEYBOOM RHB, FUCIK H, EDWARDS IR. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet 1995; 345 (8965):1638

RONCHI F, CECCHI P, FALCIONI F, MARSCIANI A, MINAK G, MURATORI G, TAZZARI PL, BEVERINI S. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Arch Dis Child. 1998; 78(3):273-274

NEAU D, BONNET F, MICHAUD M, PEREL Y, LONGY-BOURSIER M, RAGNAUD JM, GUILLARD JM. Immune thrombocytopenic purpura after recombinant hepatitis B vaccine: retrospective study of seven cases. Scand J Infect Dis. 1998; 30(2):115-8

MULLER A, KERTZSCHER F, KIEFEL V, LENK H. Thrombocytopenic purpura: adverse reaction to a combined immunisation (recombinant hepatitis B and measles-mumps-rubella-vaccine) and after therapy with Co-trimoxazole. Eur J Pediatr. 1999; 158 Suppl 3:S209-10

MAEZONO R, ESCOBAR AM. Thrombocytopenic purpura after hepatitis B vaccine. J Pediatr (Rio J). 2000; 76(5):395-8

CONESA V, NUNEZ Mf, NAVARRO JF, MOMPEL A, RUIZ J, GOMEZ A. Thrombocytopenic Purpura after Recombinant Hepatitis B Vaccine. A rare association. Haematologica. 2001; 86(3)E09

NUEVO H, NASCIMENTO-CARVALHO CM, ATHAYDE-OLIVEIRA CP, LYRA I, MOREIRA LM. Thrombocytopenic purpura after hepatitis B vaccine: case report and review of the literature. Pediatr Infect Dis J. 2004; 23(2):183-4

POLAT A, AKCA H, DAGDEVIREN E. Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey. Vaccine. 2008 Oct 14
ASHOK SHENOY K, PRABHA ADHIKARI MR, CHAKRAPANI M, SHENOY D, PILLAI A. Pancytopenia after recombinant hepatitis B vaccine, an Indian case report. Br J Haematol. 2001; 114(4):955

VIALLLARD JF, BOIRON JM, PARRENS M, MOREAU JF, RANCHIN V, REIFFERS J, LENG B, PELLEGRIN JL. Severe pancytopenia triggered by recombinant hepatitis B vaccine. Br J Haematol. 2000; 110(1):230-3
Syndrome d’Evans (anémie et thrombopénie auto-immunes)
MARTINEZ E, DOMINGO P. Evan’s syndrome triggered by recombinant hepatitis 
B vaccine. Clin. Infec. Dis. 1992; 15:1051

LLIMINANA C, SOLER JA, MELO M, ROIG I. Hemolytic anemia and thrombocytopenic purpura after the administration of the recombinant hepatitis B vaccine. Med Clin (Barc). 1999; 113(1):39
AFFECTIONS HEPATIQUES ET DIGESTIVES
Hépatite aigüe
Hépatite auto-immune
RANIERI VM. DELL’ERBA A, GENTILE A, BRUNO F, LA GIOIA V,SPAGNOLO A, SACCO R,CARUSO G,ANTONACI S, SCHIRALDI G, BRIENZA A. Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? Intensive Care Med. 1977; 23(1): 119-121

SNIDER GB. GOGATE SA. A possible systemic reaction to hepatitis B vaccine. J. Am. Med. Assoc. 1985; 253:1260-1261

RAJENDRAN V, BROOKS AP. Symptomatic reaction to hepatitis B vaccine with abnormal liver function values. Br. Med. J. 1985; 290(6480):1476

GERMANAUD J, CAUSSE X, HI TRINH D, PFAU-FANDARD B, TREPO C. A case of severe cytolysis after hepatitis B vaccination. Am. J. Med. 1995; 98:595-596

LILIC D, GHOSH SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet 1994; 344:1292-1293

GREEN C, LAKSHMIPATHI T. A case of hepatitis related to etretinate therapy and hepatitis B vaccine. Dermatologica 1991; 182:119-120

E VANS AA, LONDON WT. Hepatitis B vaccine and liver problems in U.S. children less than 6 years old. Epidemiology. 1999; 10(6):790-791

LASHERAS CARBAJO MD, PALACIOS DIEZ M, GONZALEZ DIEGO P, MARTIN SCAPA MA, CANO RUIZ A, ASENSIO VEGAS A. A case of intense cytolysis following the administration of a hepatitis B vaccine. Rev Clin Esp. 1999; 199(1):49-50

GEIER DA, GEIER MR. Hepatitis B vaccination and adult associated gastrointestinal reactions: a follow-up analysis. Hepatogastroenterology 2002; 49(48):1571-1575
LILIC D, GHOSH SK. Liver dysfunction and DNA antibodies after hepatitis B vaccination. Lancet. 1994; 344(8932):1292-1293
Maladie de Crohn et Rectocolite hémorragique

AFFECTIONS MUSCULAIRES
Fibromyalgie et Syndrome de fatigue chronique
Myofasciite à macrophages
Une bibliographie complète est disponible sur le site de l’association E3M des personnes atteintes de myofasciite à macrophages (http://www.myofasciite.fr/).

L’article princeps est :

GHERARDI RK, COQUET M, CHERIN P, BELEC L, MORETTO P, DREYFUS PA, PELISSIER JF, CHARIOT P, AUTHIER FJ. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001; 124(9):1821-1831
O’SULLIVAN SJ. Alleged link between hepatitis B vaccine ans chronic fatigue syndrome. Can Med. Assoc. J. 1992; 147:3999

DELAGE G, SALIT I, PENNIE R, ALLARY M, DUVAL B, WARD B. The possible relation between hepatitis B vaccination and chronic fatigue syndrome. Union Med. Can. 1993; 122:278-279

ANONYME Report of the working group on the possible relationship between hepatitis B vaccination and the chronic fatigue syndrome. CMAJ. 1993; 149(3):314-319

DUCLOS P. Safety of immunisation and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf. 2003; 2(3):225-31

ABLIN JN, SHOENFELD Y, BUSKILA D. Fibromyalgia, infection and vaccination: Two more parts in the etiological puzzle. J Autoimmun. 2006; 27(3):145-52

APPEL S, CHAPMAN J, SHOENFELD Y. Infection and vaccination in chronic fatigue syndrome: myth or reality? Autoimmunity. 2007; 40(1):48-53

NANCY AL, SHOENFELD Y. Chronic fatigue syndrome with autoantibodies-the result of an augmented adjuvant effect of hepatitis-B vaccine and silicone implant. Autoimmun Rev. 2008 Oct; 8(1):52-5

EXLEY C, SWARBRICK L, GHERARDI RK, AUTHIER FJ. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses. 2009 Feb; 72(2):135-9
AFFECTIONS NEUROLOGIQUES
Ataxie cérébelleuse
Autisme
DEISENHAMMER F, POHL P, BOSCH S, SCHMIDAUER C. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurol. Scand. 1994; 89:462-3
Carolyn M. GALLAGHER & Melody S. GOODMAN. Hepatitis B Vaccination of Male Neonates and Autism Diagnosis, NHIS 1997–2002. Journal of Toxicology and Environmental Health
Myélite transverse
Encéphalite, Leuco-encéphalite, Encéphalomyélite (ADEM)
MAHASSIN F, ALGAYRES JP, VALMARY J, BILIH, COUTANT G, BEQUET D, DALY JP. Myélite aiguë après vaccination contre l'hépatite B. Presse Med. 1993; 22:1997-1998

TREVISANI F, GATTINARA GC, CARACENI P, BERNARDI M, ALBERTONI F. Transverse myelitis following hepatitis B vaccination. J. Hepatol. 1993; 19:317-318

TARTAGLINO LM, HEIMAN-PATHERSON T, FRIEDMAN DP, FLANDERS AE. MR imaging in a case of postvaccination myelitis. AJNR Am J Neuroradiol 1995; 16:581-582

SENEJOUX A, ROULOT D, BELIN C,TSKIRIS L, RAUTUREAU J, COSTE T. Acute myelitis after immunization against hepatitis B with recombinant vaccine. Gastroenterol Clin Biol. 1996; 20(4) :401-402

SONG HK, KIM HC, YUN YH. Acute Myelitis after hepatitis B vaccination. J Korean Med Sci. 1997; 12(3):249-51

RENARD JL, GUILLAMO JS, RAMIREZ JM, TAILLIA H, FELTEN D, BUISSON Y. Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti-HBs antibodies. Presse Med. 1999; 28(24): 1290-1292

INIGUEZ C, MAURI JA, LARRODE P, LOPEZ DEL VAL J, JERICO I, MORALES F. Acute transverse myelitis secondary to hepatitis B vaccination Rev Neurol. 2000; 31(5):430-432

KARAAALI-SAVRUN F, ALTINTAS A, SAIP S, SIVA A. Hepatitis B vaccine related-myelitis ? Eur J Neurol. 2001; 8(6):711-715

FONSECA LF, NOCE TR, TEIXEIRA ML, TEIXEIRA AL Jr, LANA-PEIXOTO MA. Early-onset acute transverse myelitis following hepatitis B vaccination and respiratory infection: case report. Arq Neuropsiquiatr. 2003; 61(2A):265-268
MANNA R,DE SANTIS, OLIVIERO A, CARNEVALE A, CAPUTO S, PAHOR M, LAUDISIO A, GASBARRINI G. Leukoencephalitis after recombinant hepatitis B vaccine. J.Hepatol. 1996; 24(6):764-765
 
TOURBAH A, GOUT O, LIBLAU R, LYON-CAEN O, BOUGNIOT C, IBA-ZIZEN MT, CABANIS EA. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS ? Neurology. 1999; 53(2):396-401

KONSTANTINOU D, PASCHALIS C, MARAZIOTIS T, DIMOPOULOS P, BASSARIS H, SKOUTELIS A. Two episodes of leukoencephalitis associated with recombinant Hepatitis B vaccination in a single patient. Clinical Infectious Diseases. 2001; 33:1772-1773

CABRERA-GOMEZ JA, ECHAZABAL-SANTANA N, GARCIA-GONZALES L, RAMOS CEDENO AM, RODRIGUEZ ROQUE MO, LOPEZ HERNANDEZ O, CABRERA NUNEZ JA, GONZALES DE LA NUEZ J, TELLEZ L. A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination ? Rev Neurol. 2002; 34(4):358-363

HUYNH W, CORDATO DJ, KEHDI E, MASTERS LT, DEDOUSIS C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci. 2008; 15(12):1315-1322
Névralgie amyotrophique de l’épaule de Parsonage et Turner
NUTINI MT. Pharmacovigilance Hévac B Pasteur. J.Am. Med. Assoc. (supplément hors série) 1987: 5-7

REUTENS DC, DUNNE JW, LEATHER H. Neuralgic amyotrophy following recombinant DNA hepatitis B vaccination. Muscle and nerve 1990; 657: 461

VITAL C, VITAL A, GBIKPI-BENISSAN G, LONGY-BOURSIER M, CLIMAS MT, CASTAING Y, CANRON MH, LE BRAS M, PETRY K. Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases. J Peripher Nerv Syst. 2002; 7(3):163-167

JASTANIAH WA, DOBSON S, LUGSDIN JG, PETTY RE. Complex regional pain syndrome after hepatitis B vaccine. J Pediatr. 2003; 143(6):802-804

BANTZ PM, PEISER C, GRONEBERG DA. Peripheral neurological symptoms after hepatitis B virus vaccination. QJM. 2003; 96(8):611
Paralysie faciale
SHAW FE, GRAHAM DJ, GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ GL, HADLER SL, KURITSKY JN, HINER EE, BREGMAN DJ, MAYNARD JE. Postmarketing surveillance for neurological adverse events reported after hepatitis vaccination. Am. J. Epidemiol. 1988; 127:567-580

GANRY O, LERAILLER F, VERCELLETTO M, CHIFFOLEAU A, LAROUSSE C. Peripherical facial paralysis following vaccination against hepatitis B. Apropos of a case. Therapie. 1992; 47(5):437-438

PIRMOHAMED M, WISTANLEY P. Hepatitis B vaccine and neurotoxicity Postgrad Med J. 1997; 73(861):462-3
Sclérose en plaques (SEP)
Sclérose latérale amyotrophique (SLA)
HERROELEN L, DE KEYSER J, EBINGER G. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet. 1991 Nov 9; 338(8776):1174-5

NADLER JP. Multiple sclerosis and hepatitis B vaccination. Clin Infect Dis. 1993; 17(5):928-9

KAPLANSKI G, RETORNAZ F, DURAND J, SOUBEYRAND J. Central nervous system demyelination after vaccination against hepatitis B and HLA haplotype. J Neurol Neurosurg Psychiatry. 1995; 58(6):758-9

CAMPINS MARTI M, MORAGA LLOP FA. Hepatitis B and multiple sclerosis. An.Esp Pediatr. 1998; 49(6):555-557

HALSEY NA, DUCLOS P, VAN DAMME P, MARGOLIS H. Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board Pediatr Infect Dis J. 1999; 18(1):23-4

DIEGO NUNEZ MA, GONZALEZ MENENDEZ AE Vaccination against hepatitis B and multiple sclerosis An Esp Pediatr. 1999; 50(1):97

HALL A, KANE M, ROURE C, MEHEUS A. Multiple sclerosis and hepatitis B vaccine ? Vaccine. 1999; 17(20-21):2473-5

SOUBEYRAND B, BOISNARD F, BRUEL M, DEBOIS H, DELATTRE D, GAUTHIER A, SOUM S, THEBAULT C. Central nervous system demyelinating disease following hepatitis B vaccination with GenHévac B. Review of ten years of spontaneous notifications (1989-1998). Presse Med. 2000; 29(14):775-80

TERNEY D, BENICZKY S, BARSI P, KONDAKOR I, PERENYI J, FALUDI B, SZAPPER M, VECSEI L. Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient. Chin Med J (Engl). 2006; 119(1):77-9
JERUSALEM F. Amyotrophische lateralsklerose und hepatitis-B-impfung. Deutsch Med Wochensch 1987; 45:1757
Surdité brusque
BONFILS P, BIACABE B,POTARD G, AIDAN D. Fluctuant perception hearing loss after hepatitis B vaccine. Ann. Otolaryngol Chir Cervicofac. 1996; 113(6):359-361

ORLANDO MP, MASIERI S, PASCARELLA MA, CIOFALO A, FILIACI F. Sudden hearing loss in childhood consequent to hepatitis B vaccination : a case report. Ann N Y Acad Sci. 1997; 830:319-321

DE JONCKJER PH, DE SURGERES GG. Acute tinnitus and permanent audio-vestibular damage after hepatitis B vaccination. Int Tinnitus J. 2001; 7(1):59-61
Syndrome de Guillain-Barré et Polyradiculonévrite
RIBERA EF, DUTKA AJ. Polyneuropathiy associated with administration of hepatitis B vaccine. N Eng J Med. 1983; 8:614

SHAW FE, GRAHAM DJ, GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ GL, HADLER SL, KURITSKY JN, HINER EE, BREGMAN DJ, MAYNARD JE. Postmarketing surveillance for neurological adverse events reported after hepatitis vaccination. Am. J. Epidemiol. 1988; 127:567-580

TUOHY PG. Guillain Barré syndrome following immunisation with synthetic hepatitis B vaccine. New Zealand Med J 1989; 102:114-115

LIN JJ. A rare association between hepatitis B virus vaccination and Guillain Barré syndrome - a case report. Chin J Gastroenterol 1989;6:229-232

KAKAR A, SETHI PK. Guillain Barre syndrome associated with hepatitis B vaccination. Indian J Pediatr. 1997; 64(5):710-2

CREANGE A, TEMAM G, LEFAUCHEUR JP. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity. 1999; 30(3):143-146

WU Z, WU H, WANG Q, et al. A Case-control Study on Guillain-Barre Syndrome in Children of North China., Zhonghua Yu Fang Yi Xue Za Zhi. 1999 Sep; 33(5):279-81. (Chinese)

SINSAWAIWONG S, THAMPANITCHAWONG P. Guillain-Barré syndrome following recombinant hepatitis B vaccine and literature review. J Med Assoc Thai. 2000; 83(9):1124-1126

SINDERN E, SCHRODER JM, KRISMANN M, MALIN JP. Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal [correction of letal] outcome after hepatitis B vaccination. J Neurol Sci. 2001; 186(1-2):81-85

SETI NK, Guillain Barré syndrome following vaccination with hepatitis B vaccine. J Assoc Physicians India. 2002; 50:989

KHAMAISI M. Guillain Barré syndrome following hepatitis B vaccination. Clin Exp Rheumatol. 2004; 22(6):767-70

SOUAYAH N. Guillain-Barré syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine. 2007; 25(29):5253-5255
Autres affections neurologiques
HARO S. Convulsion associated with fever following hepatitis B vaccination. J. Paediatr. Child Health 1990; 26: 65

HARTMANN S. Convulsion associated with fever following hepatitis B vaccination. J Paediatr Child Health. 1990; 26(1):65

KAYGUSUZ S, ERDEMOGLU AK, KOKSAL I. Afebrile convulsion in an adult after recombinant hepatitis B vaccination. Scand J Infect Dis. 2002; 34(4):314-5

MARSAUDON E, BARRAULT MF. Meningeal reaction after vaccination against hepatitis B. Presse Med. 1996; 25(32):1561-1562

HEINZLEF O,MOGUILEWSKI A, ROULLET E. Acute aseptic meningitis after hepatitis B vaccination. Presse Med 1997; 26(7):328

MAILLEFERT JF, FARGE P, GAZET-MAILLEFERT MP, TAVERNIER C Mental nerve neuropathy as a result of hepatitis B vaccination. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Jun; 83(6):663-4

PIRMOHAMED M, WINSTANLEY P. Hepatitis B vaccine and neurotoxicity. Postgrad Med J. 1997; 73(861):462-463
AFFECTIONS OPHTALMOLOGIQUES
Epithéliopathie en plaques
ARYA SC. Ophtalmic complications of vaccines against hepatitis B virus. Ophtalmol 1997; 21(3):177-178
SINGH VK,KALRA K,YAMAKI K, ABE T, DONOSO L, SHINOHARA T. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides : induction of experimental autoimmune uveitis in Lewis rats. J.Immunol.1990; 144:1282-1287
 
BREZIN AP,LAUTIER-FRAU M,HAMEDANI M, ROGEAUX O, LEHOANG P. Visual loss and eosinophilia after recombinant hepatitis B Vaccine. Lancet 1993; 28:563-4

BREZIN AP, MASSIN-KOROBELNIK P, BOUDIN M, GAUDRIC A, LEHOANG P. Acute posterior multifocal placoid pigment epitheliopathy after hepatitis B vaccine. Arch. Ophtalmol. 1995; 113:297-300

BOURGES JL, PISELLA PJ, LAURENS C, LIMON S. Multifocal placoid epitheliopathy and anti-hepatitis B vaccination. J Fr Ophtalmol. 1998; 21(9):696-700
Neuropapillite
BERKMAN N, BENZARTI T, DHAOUI R, MOULY P. Neuropapillite bilatérale au décours de la vaccination contre l’hépatite virale B. Presse Méd. 1996; 25:1301
Névrite optique
SHAW FE, GRAHAM DJ, GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ GL, HADLER SL, KURITSKY JN, HINER EE, BREGMAN DJ, MAYNARD JE. Postmarketing surveillance for neurological adverse events reported after hepatitis vaccination. Am. J. Epidemiol. 1988; 127:567-580

ALABITAR S, BOURGEON B, GENIN R, FEN-CHONG M, N'GUYEN P, SERVEAUX MO, ATCHIA H, SCHOHN D., Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrol Dial Transplant. 1997; 12(10):2169-2170

FLEDELIUS HC. Unilateral papilloedema after hepatitis B vaccination in a migraine patient. A case report including forensic aspects. Acta Ophthalmol Scand. 1999; 77(6):722-724

STEWART O, CHANG B, BRADBURY J. Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis Br J Ophthalmol. 1999; 83(10):1200-1201

VOIGT U, BAUM U, BEHRENDT W, HEGEMANN S, TERBORG C, STROBEL J. Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever. Klin Monatsbl Augenheilkd. 2001; 218(10):688-690
Occlusion de la veine centrale de la rétine
DEVIN F, ROQUES G, DISDIER P, RODOR F, WEILLER PJ. Occlusi on of central retinal vein after hepatitis B vaccination. Lancet 1996; 347:1626

GRANEL B, DISDIER P, DEVIN F, SWIADER L, RISS JM, COUPIER L, HARLE JR, JOUGLARD J, WEILLER PJ. Occlusion of the central retinal vein after vaccination against viral hepatitis B with recombinant vaccines. 4 cases. Presse Méd. 1997; 26(2):62-65

BERKMAN N. Un cas d’occlusion parcellaire et unilatérale de la veine centrale de la rétine au décours d’une vaccination contre l’hépatite B. Presse Méd. 1997; 26(14):670
Uvéite postérieure
FRIED M, CONEN D, CONZELMANN M, STEINEMANN E. Uveitis after hepatitis B vaccination. Lancet 1987; 12:631-632

MURRAY PI, PRASAD J, RAHI AH. Status of hepatitis B virus in the aetiology of uveitis in Great Britain. Br. J. Ophtalmol. 1983; 67:685-687
Taches blanches multiples évanescentes
BAGLIVO E, SAFRAN AB, BORRUAT FX. Multiple evanescent white dot syndrome after hepatitis B vaccine. Am J. Ophtalmol.1996; 122(3):431-432
AFFECTIONS RHUMATOLOGIQUES
Arthrites réactionnelles
Polyarthrite Rhumatoïde
CHRISTIAN B, HELIN P. Reactive arthritis following vaccination against hepatitis B. Ugeskr Laeger 1987; 149(28):1882

HACHULLA E, HOUVENAGEL E, MINGUI A, VINCENT G, LAINE A. Reactive arthritis after hepatitis B vaccination. J.Rheumatol.1990; 17:1250-1251

ROGERSON ST , NYE FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. Br. Med. J.1990; 301:345

BIASI D, DE SANDRE G, BAMBARA LM, CARLETTO A, CARAMASCHI P, ZANONI G, TRIDENTE G. A new case of reactive arthritis after hepatitis B vaccination. Clinic. and Experimental Rheumatology 1991;11(2):215

BIASI D, CARLETTO A, CARAMASCHI P, FRIGO A, PACOR ML, BEZZI D, BAMBARA LM. Rheumatological manifestations following hepatitis B vaccination. Report of two clinical cases. Recenti Progressi in Med. 1994; 85:438-440

HASSAN W, OLDHAM R. Reiter’s syndrome and reactive arthritis in health care workers after vaccination. Br.Med.J.1994; 309:94

FRASER PA, WILSON JD. Reiter’s syndrome attributed to hepatitis B immunization. Br Med.J. 1994; 309:1513

BIRLEY HD, ARYA OP. Hepatitis B immunisation and reactive arthritis. Br. Med. J. 1994; 309(6967):1514  
 
GROSS K, COMBE C, KRUGER K, SCHATTENKIRCHNER M. Arthritis after hepatitis B vaccination: report of three cases. Scand. J. Rheumatol.1995; 24:50-2

CATHEBRAS, CARTRY O,LAFAGE-PROUST H,LAUWERS A,ACQUART S,THOMAS T,ROUSSET H. Arthritis, hypercalcemia and lytic bone lesions after hepatitis B vaccination. J. Rheumatol. 1996; 23(3):558-560

CASALS JL, VAZGUEZ MA. Arthritis induced by antihepatitis B vaccine. An Med Interna. 1999; 16(11):601-602
RAU R, KARGER T, HERBORN G. Two cases of chronic polyarthritis after hepatitis vaccination. Z Rheumatol. 1984; 43:213

ROGERSON ST , NYE FJ. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. Br. Med. J.1990; 301:345

SYMMONS DPM, CHAKRAVARTY K. Can immunization trigger rheumatoid arthritis? Ann Rheumatol. Dis.1993;52:843-844

VAUTIER G, CARTY JE. Acute sero-positive rheumatoid arthritis occuring after hepatitis B vaccination. Br.J.Rheumatol. 1994 ;33:991-998

BANNWARTH B. Drug-induced rheumatic disorders. Rev Rhum Engl Ed. 1996 Nov; 63(10):639-647

BRACCHI M, ZOPPINI A. Polyarthritis associated with hepatitis B vaccination. Br.J.Rheumatl. 1997; 36(2):300-301

TREVES R. LACOSTE L, BONTOUX D, PITROU E, BERIN P, BONNET C. Erosive nodular rheumatoid arthritis triggered by hepatitis B vaccination. Presse Méd. 1997; 26(14):670

SOUBRIER M, DUBOST JJ, BIELSA C, RISTORI JM, BUSSIERE JL. Polyarthrite érosive déclenchée par une vaccination contre l'Hépatite B. Presse Méd. 1997; 26(2):75

POPE JE, STEVENS A, HOWSON W, BELL DA: The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J. Rheumatology 1998; 25(9):1687-1693

SEBAG O, BOLLA G, BEBIN B, SEBAG F. Exacerbation of chronic juvenile arthritis induced by hepatitis B vaccination. Arch Pediatr. 1998; 5(9):1046

MAILLEFERT J F, SIBILIA J, TOUSSIROT E, VIGNON E, ESCHARD JP, LORCERIE B, JUVIN R, PARCHIN-GENESTE N, PIROTH C, WENDLING D, KUNTZ JL, TAVERNIER C, GAUDIN P : Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford). 1999; 38(10):978-983

FISHER MA, EKLUND SA, JAMES SA,LIN X. Adverse events associated with hepatitis B vaccine in US. Children less than six years of age, 1993 and 1994. Annals Epidemiol. 2001; 11 (1):13-21
Spondylarthrite ankylosante

PATHOLOGIES DIVERSES
Glomérulonéphrite
Péricardite
NUTINI MT, MARIE FN, LOUCQ C, TRON F. Hepatitis B vaccine : clinical experience and safety. Lancet 1982; 2:1301

CARMELY Y, OREN R. Hepatitis B side-effet. Lancet 1993; 341(8839):250-251

PENNESI M, TORRE G, DEL SANTO M, SONZOGNI A. Glomerulonephritis after recombinant hepatitis B vaccine. Pediatr Infect Dis J. 2002 Feb; 21(2):172-3
BENSAID J, DENIS F. Péricardite aigüe bénigne après vaccination contre l'hépatite B. Press. Med. 1993; 22:269

CAILLARD JF, BASTARD C, CZERNIKOW P, LEMARCHAND C, PROUST B, PRUDENT P. Effets secondaires de la vaccination contre l’hépatite à virus B. Etude sur 1047 sujets au CHU de Rouen. Larc médical. 1985; 5:129-132

PEYRIERE H, HILLAIRE-BUYS D, PONS M, NAVARRE C, DAVY JM, BLAYAC JP. Acute pericarditis after vaccination against hepatitis B: a rare effect to be known. Rev. Med. Interne 1997; 18:675-676
Pathologie néo-natale
NIU MT, SALIVE ME, ELLENBERG SS. Neonatal death after hepatitis B vaccine. The VAERS 1991-1998.Arch Pediatr Adolesc Med. 1999;153:1279-1282

STAJICH GV, LOPEZ GP, HARRY SW, SEXSON WR. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J.Pediatr.2000 ;136(5) : 679-681

AFSSAPS. Information sur les vaccins Hexavalents : Hexavac® et InfanrixHexa®

Communiqué de presse du 9 décembre 2003, accessible en ligne à : http://ansm.sante.fr/S-informer/Presse-Communiques-Points-presse/Information-sur-les-vaccins-Hexavalents-Hexavac-R-et-InfanrixHexa-R
ÉTUDES ÉPIDEMIOLOGIQUES
ÉTUDES PHYSIO-PATHOLOGIQUES et REVUES GÉNÉRALES
SHAW FE, GRAHAM DJ, GUESS HA, MILSTIEN JB, JOHNSON JM, SCHATZ GL, HADLER SL, KURITSKY JN, HINER EE, BREGMAN DJ, MAYNARD JE. Postmarketing surveillance for neurological adverse events reported after hepatitis vaccination. Am. J. Epidemiol. 1988; 127:567-580

DUCLOS P. Adverse events after hepatitis B vaccination. CMAJ. 1992; 147(7):1023-1026

TOSTI ME, TRAVERSA G, BUIANCO E, MELE A. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile. Ital J. Gastroenterol Hepatol. 1999; 31(5):388-391

ZIPP F, WEIL JG, EINHAUPL KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med. 1999; 5(9):964-965

SADOVNICK AD, SCHEIFELE DW. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet. 2000; 355:549-50

SOUBEYRAND B, BOISNARD F, BRUEL M, DEBOIS H, DELATTRE D, GAUTHIER A, SOUM S, THEBAULT C. Central nervous system demyelinating disease following hepatitis B vaccination with GenHévac B. Review of ten years of spontaneous notifications (1989-1998). Presse Med. 2000; 29(14):775-780

TOUZE E, GOUT O, VERDIER-TAILLEFER MH, LYON-CAEN O, ALPEROVITCH A. The first episode of central nervous system demyelinization and hepatitis B vaccination. A pilot case-control study. Rev Neurol. 2000; 156:242-6

STURKENBOOM MCJM, ABENHAIM L, WOLFSON C, ROULET E, HEINZELF O, GOUT O. Vaccinations, demyelination and multiple sclerosis study (VDAMS). Pharmacoepidemiol Drug Safety. 1999; 8:S170-1

ASCHERIO A, ZHANG SM, HERNAN MA, OLEK MJ, COPLAN PM, BRODOVICZ K, WALKER AM. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001 Feb 1; 344(5):327-332

BEGAUD B, ALPEROVITCH A. Vaccinations and multiple sclerosis. N Engl J Med. 2001; 344(23):1793 ( author reply 1795)

GOUT O. Vaccinations and multiple sclerosis. N Engl J Med. 2001; 344(23):1794 (author reply 1795)

HOSTETLER L. Vaccinations and multiple sclerosis. N Engl J.Med. 2001; 344(23):1795 (author reply 1795)

STURKENBOOM MC, FOURRIER A. Vaccinations and multiple sclerosis. N Engl J Med. 2001 Jun 7; 344(23):1794 (author reply 1795)

HANSLIK T, VIBOUD C, FLAHAULT A. Vaccinations and multiple sclerosis. N Engl J Med. 2001; 344(23):1793-4 (author reply 1795-6)

FOURRIER A, BEGAUD B, ALPEROVITCH A, VERDIER-TAILLEFER MH, TOUZE E, DECKER N, IMBS JL Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: a comparison between reported and expected number of cases. British Journal of Clinical Pharmacology. 2001; 51 (5):489

Mc INTYRE CR. Hepatitis B vaccine: risks and benefits of universal neonatal vaccination. J Paediatr Child Health. 2001; 37(3):215-217

TOUZÉ E, FOURRIER A, RUE-FENOUCHE C, RONDE-OUSTAU V, JEANTAUD I, BEGAUD B, ALAPEROVITCH A. Hepatitis B vaccination and first central nervous system demyelinating event : a case-control study. Neuroepidemiology. 2002; 21(4):180-186

JEFFERSON T, TRAVERSA G. Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation. J Med Virol. 2002; 67(3):451-3

CONFAVREUX C. Hepatitis B vaccination and multiple sclerosis: where are we ? Rev Prat. 2002; 52(19):2093-5

GEIER MR, GEIER DA. Hepatitis B vaccination safety. Ann Pharmacother 2002; 36:370-374
 
GEIER DA, GEIER MR. Chronic adverse reactions associated with hepatitis B vaccination. Ann Pharmacother 2002; 36:1970–1971

DESTEPHANO F, VERSTRAETEN T, CHEN RT. Hepatitis B vaccine and risk of multiple sclerosis. Expert Rev Vaccines. 2002; 1(4):461-6

DESTEPHANO F, VERSTRAETEN T, JACKSON LA, OKORO CA, BENSON P, BLACK SB, SHINEFIELD HR, MULLOLY JP, LIKOSKY W, CHEN RT; Vaccine Safety Datalink Research Group, National Immunization Program, Centers for Disease Control and Prevention. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol. 2003; 60(4):504-509

DUCLOS P. Safety of immunisation and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf. 2003 May; 2(3):225-31
 
IMBS JL, DECKER N, WELSCH M. Pharmacovigilance of hepatitis B vaccines. Bull Acad Natl Med. 2003; 187(8):1489-1498; discussion 1498-5000

GEIER MR, GEIER DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clin Exp Rheumatol. 2004; 22(6):749-755

HERNAN MA, JICK SS, OLEK MJ, JICK H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2004; 63(5):838-842

McINTYRE CR, KELLY H, JOLLEY D, BUTZKUEVEN H, SALMON D, HALSEY N, MOULTON LH. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study. Neurology. 2005; 64(7):1317 (author reply)

DESTEFANO F, WEINTRAUB ES, CHEN RT. Recombinant hepatitis B vaccine and the risk of multiple sclerosis : a prospective study. Neurology. 2005; 64(7):1317 (author reply)

GEIER DA. GEIER MR A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity. 2005; 38(4):295-301

HERNAN MA, JICK SS. Hepatitis B vaccination and multiple sclerosis : the jury is still out. Pharmacoepidemiol Drug Saf. 2006; 15(9):653-655

SALLERAS L, BRUGERA M, PRAT A. Hepatitis B vaccine and multiple sclerosis: an unproved association. Med Clin (Barc). 2006 Apr 22; 126(15):581-588

MIKAELOFF Y, CARIDADE G, ASSI S, TARDIEU M, SUISSA S; KIDSEP study group of the French Neuropaediatric Society. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain. 2007; 130(Pt4):1105-1110

HOCINE MN , FARRINGTON CP, TOUZE E, WHITAKER HJ, FOURRIER A, MOREAU T, TUBER-BITTER P. Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method. Vaccine. 2007; 25(31):5938-43

MIKAELOFF Y, CARIDADE G, ROSSIER M, SUISSA S, TARDIEU M. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Arch Pediatr Adolesc Med. 2007; 161(12):1176-1182

MIKAELOFF Y, CARIDADE G, SUISSA S, TARDIEU M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology. 2008 Oct 8. [Epub ahead of print]

COSTAGLIOLA D. Central nervous system demyelinating events and hepatitis B vaccine : a new episode of the never ending French saga! Rev Epidemiol Sante Publique. 2008; 56(6):379-381
CARMELY Y, DE-MEDINA T. Serious hepatitis B vaccine adverse reaction are they immune-mediated? Vaccine 1993; 11(13):1358-1359

PIRMOHAMED M, WINSTANLEY P. Hepatitis B vaccine and neurotoxicity. Postgrad Med J. 1997; 73(861):462-463

GROTTO I, MANDEL Y, EPHROS M, ASHKENAZI I, SHEMER J. Major adverse reactions to yeast-derived hepatitis B vaccines-a review. Vaccine. 1998;16(4):329-334

CAMPINS MARTI M, MORAGA LLOP FA. Hepatitis B vaccine and multiple sclerosis An Esp Pediatr. 1998; 49(6):555-557.

DIEGO NUNEZ MA, GONZALEZ MENENDEZ AE. Vaccination against hepatitis B and multiple sclerosis. An Esp Pediatr. 1999;50(1):97

HALL A, KANE M, ROURE C, MEHEUS A. Multiple sclerosis and hepatitis B vaccine ? Vaccine. 1999; 17(20-21):2473-2475

CARMELY Y, OREN R. Hepatitis B side-effet. Lancet 1993;341(8839):250-251

SHOENFELD Y, ARON-MAOR A. Vaccination and autoimmunity-“vaccinosis” : a dangerous liaison ? J. Autoimmun. 2000; 14(1):1-10.

MONTEYNE P, ANDRE FE. Is there a causal link between hepatitis B vaccination and multiple sclerosis ? Vaccine. 2000; 18(19):1994-2001

JEFFERSON T, HEIJBEL H. Demyelinating disease and hepatitis B vaccination : is there a link ? Drug Saf. 2001; 24(4):249-254

CHEN RT, PLESS R, DESTEFANO F. Epidemiology of autoimmune reactions induced by vaccination. J Autoimmun. 2001; 16(3):309-18

ARON E. Hepatitis B vaccination. Advocating for a protection principle. Bull Acad Natl Med. 2002; 186(2):361-6; discussion 366-8

CONFAVREUX C. Hepatitis B vaccination and multiple sclerosis : where are we ? Rev Prat. 2002; 52(19):2093-5

PIYASIRISILP S, HEMACHUDHA T. Neurological adverse events associated with vaccination. Curr Opin Neurol. 2002; 15(3):333-8

RUTSCHMANN OT, Mc CRORY DC, MATCHAR DB. Immunization Panel of the Multiple Sclerosis Council for Clinical Practice Guidelines; Immunization and MS: a summary of published evidence and recommendations. Neurology. 2002; 59(12): 837-883

JEFFERSON T, TRAVERSA G. Hepatitis B vaccination: risk-benefit profile and the role of systematic reviews in the assessment of causality of adverse events following immunisation. J Med Virol. 2002; 67(3):451-3

GOUT O. Vaccinations and multiple sclerosis. Neurol Sci. 2001; 22(2):151-154

DEMICHELI V, RIVETTI A, DI PIETRANTONI C, CLEMENTS CJ, JEFFERSON T. Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review. J Viral Hepat. 2003; 10(5):343-4

DUCLOS P. Safety of immunisation and adverse events following vaccination against hepatitis B. Expert Opin Drug Saf. 2003;2(3):225-31

GOUT O, LYON-CAEN O. Current opinion 2004: The relationship between multiple sclerosis and hepatitis B vaccination in adults. Rev Neurol (Paris) 2004; 160(12):1147-1149

VIAL T, DESCOTTES J. Autoimmune diseases and vaccinations. Eur J Dermatol. 2004; 14:86-90

PIAGGIO E, BEN YOUNES A, DESBOIS S, GOUT O, TOURBAH A, LYON-CAEN O, LIBLAU RS. Hepatitis B vaccination and central nervous system demyelination: an immunological approach. J Autoimmun. 2005 Feb; 24(1):33-37

FAURE E. Multiple sclerosis and hepatitis B vaccination : could minute contamination of the vaccine by partial hepatitis B virus polymerase play a role through molecular mimicry ? Med Hypotheses. 2005; 65(3):509-520

GIRARD M. Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev. 2005; 4(2):96-100

GIRARD M. Vaccines in the 21st century : the genetic response and the innocent bystander. Autoimmun rev. 2005; 4:79-81

COMENGE Y, GIRARD M. Multiple sclerosis and hepatitis B vaccination : adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence. Med Hypotheses. 2006; 66(1):84-86

BOGDANOS DP, SMITH H, MA Y, BAUM H, MIELI-VERGANI G, VERGANI D. A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics. Clin Dev Immunol. 2005 Sep; 12(3):217-224

SCHATTNER A. Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23:3876-3886

OZAKBAS S, IDIMAN E, YULUG B, PAKOZ B, BAHAR H, GULAY Z. Development of multiple sclerosis after vaccination against hepatitis B: a study based on human leukocyte antigen haplotypes. Tissue Antigens. 2006 Sep; 68(3):235-238

WAISBREN BA Sr. Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns. Med Hypotheses. 2008; 70(2):346-8
THESES SUR LES EFFETS INDESIRABLES DE LA VACCINATION ANTI-HB
GRÉZARD Pierre : ACCIDENTS DE LA VACCINATION CONTRE L’HEPATITE B : A PROPOS DE 9 CAS OBSERVES DE DEBUT 1994 A FIN 1995 - Année 1996 – Université Claude Bernard LYON I GRANGE-BLANCHE

SOBOTA Christophe : EFFETS INDESIRABLES DES VACCINS RECOMBINANTS CONTRE L'HÉ PATITE B. Année 1997 - N° 97/121 - Université d’AMIENS

RIDONY Catherine : EFFETS SECONDAIRES DU VACCIN CONTRE L'H É PATITE B : A PROPOS DE QUATRE CAS - Année 1997 - thèse n° 97/AIX2/0079. Université d’AIX MARSEILLE 2

RÉGNIER Jérôme : AFFECTIONS DÉ MYÉ LINISANTES CENTRALES ET VACCINATION CONTRE L'HÉPATITE B DANS LE NORD PAS DE CALAIS : A PROPOS DE 25 CAS - Année 1998 - Université LILLE 2

DUBERTRET Catherine : QUATRE CAS DE LYMPHOCYTOME CUTANE BENIN APRES VACCINATION PAR L'HEPATITE B. Année 1998. Thèse n° 1092/1998. Université de PARIS 6, PITIE SALPETRIERE

BOUGNIOT Catherine : ENCEPHALOMYELITES POST VACCINALES APRES VACCINATION CONTRE L'HEPATITE B : A PROPOS DE 8 OBSERVATIONS . Année 1998.Thèse N° 2038. Université PARIS 7, LARIBOISIERE

FIQUET Elsa : LE VACCIN CONTRE L’HÉ PATITE B EN FRANCE : POLÉMIQUE AUTOUR DES ASPECTS MÉDICAUX, SCIENTIFIQUES, JURIDIQUES ET MÉDIATIQUES – Thèse de Doctorat en Pharmacie - 30 mai 2008 – Université Claude Bernard LYON I –Thèse accessible et téléchargeable sur Internet à l’adresse : http://jchampavere.free.fr/hepatite_b/